These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1438022)

  • 1. Class III antiarrhythmic action and inotropy: effects of almokalant in acute ischaemic heart failure in dogs.
    Mortensen E; Yang T; Refsum H
    Pharmacol Toxicol; 1992 Jun; 70(6 Pt 1):443-7. PubMed ID: 1438022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Class III antiarrhythmic action and inotropy: effects of dofetilide in acute ischemic heart failure in dogs.
    Mortensen E; Yang T; Refsum H
    J Cardiovasc Pharmacol; 1992 Feb; 19(2):216-21. PubMed ID: 1376791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of frequency dependency of the class III effects of almokalant: a study using programmed stimulation and recording of monophasic action potentials and ventricular paced QT intervals.
    Darpö B; Almgren O; Bergstrand R; Franzén S; Edvardsson N
    Cardiovasc Drugs Ther; 1996 Nov; 10(5):539-47. PubMed ID: 8950068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levosimendan enhances left ventricular systolic and diastolic function in conscious dogs with pacing-induced cardiomyopathy.
    Pagel PS; McGough MF; Hettrick DA; Lowe D; Tessmer JP; Jamali IN; Warltier DC
    J Cardiovasc Pharmacol; 1997 May; 29(5):563-73. PubMed ID: 9213196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemodynamic and metabolic effects of the antiarrhythmic drug melperone during acute left ventricular failure in dogs.
    Smiseth OA; Platou ES; Refsum H; Mjøs OD
    Cardiovasc Res; 1981 Dec; 15(12):724-30. PubMed ID: 7326689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular effects of the calcium sensitizer, levosimendan, in heart failure induced by rapid pacing in the presence of aortic constriction.
    Udvary E; Papp JG; Végh A
    Br J Pharmacol; 1995 Feb; 114(3):656-61. PubMed ID: 7735692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic effects of d-sotalol in acute ischemic heart failure in dogs.
    Mortensen E; Tande PM; Kløw NE; Refsum H
    Am Heart J; 1992 Apr; 123(4 Pt 1):970-7. PubMed ID: 1550007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of toborinone on myocardial oxygen consumption in pacing-induced heart failure dogs.
    Itoh S; Mori T; Fujiki H; Tominaga M
    Arzneimittelforschung; 1996 Dec; 46(12):1105-9. PubMed ID: 9006782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophysiologic and hemodynamic effects of H 234/09 (almokalant), quinidine, and (+)-sotalol in the anesthetized dog.
    Duker G; Almgren O; Carlsson L
    J Cardiovasc Pharmacol; 1992 Sep; 20(3):458-65. PubMed ID: 1279293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrophysiological, rate dependent, and autonomic effects of the class III antiarrhythmic almokalant after myocardial infarction in the pig.
    Tuininga YS; De Langen CD; Crijns HJ; Wiesfeld AC; Mook PH; Bel KJ; Lie KI
    Pacing Clin Electrophysiol; 1996 May; 19(5):802-10. PubMed ID: 8734747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A reproducible and stable model of acute ischaemic left ventricular failure in dogs.
    Smiseth OA; Mjøs OD
    Clin Physiol; 1982 Jun; 2(3):225-39. PubMed ID: 6889941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective Ik blocker almokalant exhibits class III--specific effects on the repolarization and refractoriness of the human heart: a study of healthy volunteers using right ventricular monophasic action potential recordings.
    Darpö B; Vallin H; Almgren O; Bergstrand R; Insulander P; Edvardsson N
    J Cardiovasc Pharmacol; 1995 Oct; 26(4):530-40. PubMed ID: 8569212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the acute electrophysiologic effects of intravenous dronedarone, an amiodarone-like agent, with special emphasis on ventricular repolarization and acquired torsade de pointes arrhythmias.
    Verduyn SC; Vos MA; Leunissen HD; van Opstal JM; Wellens HJ
    J Cardiovasc Pharmacol; 1999 Feb; 33(2):212-22. PubMed ID: 10028928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of DPI 201-106, a novel cardiotonic agent, on hemodynamics, cardiac electrophysiology and arrhythmias induced by programmed ventricular stimulation in dogs with subacute myocardial infarction: a comparative study with dobutamine.
    Ozaki T; Uematsu T; Nagashima S; Nishimoto M; Nakashima M
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Oct; 344(4):478-87. PubMed ID: 1766473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electropharmacologic effects and pharmacokinetics of almokalant, a new class III antiarrhythmic, in patients with healed or healing myocardial infarcts and complex ventricular arrhythmias.
    Wiesfeld AC; Crijns HJ; Tobé TJ; Almgren O; Bergstrand RH; Aberg J; Haaksma J; Lie KI
    Am J Cardiol; 1992 Oct; 70(11):990-6. PubMed ID: 1384304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac electrophysiologic and inotropic actions of new and potent methanesulfonanilide class III antiarrhythmic agents in anesthetized dogs.
    Wallace AA; Stupienski RF; Brookes LM; Selnick HG; Claremon DA; Lynch JJ
    J Cardiovasc Pharmacol; 1991 Nov; 18(5):687-95. PubMed ID: 1723765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rate-dependent effects of the class III antiarrhythmic drug almokalant on refractoriness in the pig.
    Wiesfeld AC; De Langen CD; Crijns HJ; Bel KJ; Hillege HL; Wesseling H; Lie KI
    J Cardiovasc Pharmacol; 1996 Apr; 27(4):594-600. PubMed ID: 8847879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular effects of (2RS,3SR)- 2-aminomethyl-2,3,7,8-tetrahydro-2,3,5,8,8-pentamethyl-6H-furo- [2,3-e]indol-7-one hydrochloride (UK-1745), a novel cardiotonic agent with vasodilatory and antiarrhythmic properties.
    Uchida Y; Kawada M; Sawanobori K; Sonoki H; Inoue K; Mizuno K; Itou T; Tabunoki Y; Tsukamoto M; Ohashi Y; Kyotani Y; Shimizu N; Fujii M; Nakamura M
    Arzneimittelforschung; 1998 Mar; 48(3):219-31. PubMed ID: 9553677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic and myocardial energetic effects of CK-3197, a selective positive inotropic agent.
    Greenberg S; Touhey B
    J Cardiovasc Pharmacol; 1991 Jan; 17(1):145-53. PubMed ID: 1708048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of denopamine (TA-064), a new positive inotropic agent, on myocardial oxygen consumption and left ventricular dimension in anesthetized dogs.
    Ikeo T; Nagao T
    Jpn J Pharmacol; 1985 Oct; 39(2):179-89. PubMed ID: 4087565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.